MedTrace Logo

Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases

NCT01970644 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2016-05-30

No results posted yet for this study

Summary

Cancer which spreads to the brain (brain metastases) is a common and significant problem. Historically, whole-brain radiotherapy has been used to treat these patients but has a negative effect on cognition. Radiosurgery is an alternative treatment with potential for fewer cognitive side effects. The impact of radiosurgery alone on the cognitive function of patients with multiple brain metastases is not well studied. We propose a pilot study at the Winnipeg Centre for Gamma Knife Surgery to examine this issue.

Conditions

  • Neoplasm Metastases

Interventions

RADIATION

Gamma knife radiosurgery

Depending on maximum tumour diameter, patients will receive a single dose of 15-20 Gy to the isodose surface which encompasses the entire metastasis.

Sponsors & Collaborators

  • Health Sciences Centre Foundation, Manitoba

    collaborator OTHER

  • CancerCare Manitoba

    lead OTHER

Principal Investigators

  • Harvey Quon, MD · CancerCare Manitoba

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01970644 on ClinicalTrials.gov